Company Announcements

Result of AGM & GM

Source: RNS
RNS Number : 4373Y
GlaxoSmithKline PLC
08 May 2019
 

GlaxoSmithKline plc

 

Result of Annual General Meeting and General Meeting

 

GlaxoSmithKline plc ('GSK') announces that at its Annual General Meeting ('AGM') and General Meeting today, all resolutions were passed by shareholders. The full text of the resolutions considered are contained in the 2019 Notice of AGM and the sole resolution of the General Meeting is contained in the Circular to Shareholders and Notice of General Meeting.  These documents are available on the GSK website at www.gsk.com.

 

GSK AGM Poll Results

 

The following table shows the total number of votes cast for each resolution:

 

Resolution

Total votes for*

%

Total votes against

%

Total votes cast

Votes withheld**

1

Receive and adopt the 2018 Annual Report

3,556,826,649

99.95

1,863,433

0.05

3,558,690,082

7,283,024

2

Approve the Annual report on remuneration  

3,157,857,593

88.77

399,443,579

11.23

3,557,301,172

8,672,905

3

Election of Iain Mackay

3,509,580,387

98.56

51,394,236

1.44

3,560,974,623

4,999,291

4

Re-election of Philip Hampton

3,523,220,874

98.94

37,814,132

1.06

3,561,035,006

4,939,054

5

Re-election of Emma Walmsley

3,543,610,930

99.50

17,645,007

0.50

3,561,255,937

4,724,016

6

Re-election of Vindi Banga

3,520,241,639

98.87

40,257,748

1.13

3,560,499,387

5,474,256

7

Re-election of Dr Hal Barron

3,542,101,484

99.46

19,107,976

0.54

3,561,209,460

4,763,464

8

Re-election of Dr Vivienne Cox

3,494,225,537

98.85

40,751,267

1.15

3,534,976,804

30,997,813

9

Re-election of Lynn Elsenhans

3,543,230,972

99.50

17,848,986

0.50

3,561,079,958

4,893,685

10

Election of Dr Laurie Glimcher

3,543,924,853

99.52

17,255,115

0.48

3,561,179,968

4,793,241

11

Re-election of Dr Jesse Goodman

3,543,465,739

99.50

17,643,172

0.50

3,561,108,911

4,864,732

12

Re-election of Judy Lewent

3,513,131,684

98.66

47,693,254

1.34

3,560,824,938

5,154,954

13

Re-election of Urs Rohner

3,434,585,693

96.46

126,031,133

3.54

3,560,616,826

5,356,667

14

Re-appointment the auditor

3,557,236,743

99.88

4,327,420

0.12

3,561,564,163

4,412,192

15

Remuneration of auditor

3,554,992,184

99.83

6,020,952

0.17

3,561,013,136

4,948,179

16

Authority for the company to make donations to political organisations and incur political expenditure

3,471,514,277

98.00

70,681,915

2.00

3,542,196,192

23,791,786

17

Authority to allot shares

3,444,525,603

96.77

114,953,481

3.23

3,559,479,084

6,482,169

18

Disapplication of pre-emption rights - general power***

3,480,629,187

97.84

76,741,126

2.16

3,557,370,313

8,607,071

19

Disapplication of pre-emption rights - in connection with an acquisition or specified capital investment***

3,390,801,857

95.31

166,798,143

4.69

3,557,600,000

8,370,163

20

Authority for the company to purchase its own shares***

3,509,141,893

98.57

50,794,321

1.43

3,559,936,214

6,028,543

21

Exemption from statement of senior statutory auditor's name

3,524,087,916

99.51

17,395,554

0.49

3,541,483,470

24,488,266

22

Authority for reduced notice of a general meeting other than an AGM***

3,271,677,728

92.38

269,908,346

7.62

3,541,586,074

24,387,840

 

 

 

 

GSK General Meeting Poll Results

 

The following table shows the total number of votes cast for the resolution:

 

Resolution

Total votes for*

%

Total votes against

%

Total votes cast

Votes withheld**

1

To approve the transaction between GlaxoSmithKline plc, GlaxoSmithKline Consumer Healthcare Holdings Limited and Pfizer, Inc for the purposes of Chapter 11 of the Listing Rules of the Financial Conduct Authority

3,496,633,023

99.85

5,302,329

0.15

3,501,935,352

24,272,073

 

Notes:

*

Includes discretionary votes. In line with the notification issued to American Depositary Receipt (ADR) holders earlier this year, GSK did not instruct its ADR Depositary to vote any unvoted ADRs in respect of the resolutions for the 2019 AGM and GM

**

A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes "For" or "Against" a resolution.

***

Indicates Special Resolutions requiring a 75% majority.

 

The above poll results will shortly be available on the Company's website at www.gsk.com. In accordance with Listing Rule 9.6.2, a copy of the resolutions, other than those concerning ordinary business, will be submitted to the UK Listing Authority and will in due course be available for inspection at www.morningstar.co.uk/uk/NSM

 

Simon Dingemans did not stand for re-election as a Director and retired from the Board with effect from the conclusion of the AGM.

 

In accordance with section 430(2B) of the Companies Act 2006, GSK confirms that Simon Dingemans will receive payment of fees for service whilst a Director, but no other remuneration payment or payment for loss of office will be made in connection with his departure.

 

The following table provides further relevant information:

 


 

GSK's

Nineteenth

AGM

(2019)

 

GSK's

Eighteenth

AGM

(2018)

Issued share capital (excluding Treasury Shares)

4,987,806,108

4,959,302,644

Total votes cast and votes withheld lodged as a % of GSK's issued share capital (excluding Treasury Shares)

71.49%

78.76%

Total shareholder population

108,698

112,326

Total number of proxies lodged

6,635

6,931

% of shareholders who lodged proxies

6.10%

6.17%

Number of shareholders, corporate representatives and proxies who attended the AGM

241

415

 

 

 

 

V A Whyte

Company Secretary

8 May 2019


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RAGUGUMGAUPBGMR